Report overview
The global Complicated Skin and Skin Structure Infections Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Tedizolid Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Complicated Skin and Skin Structure Infections Drugs include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann-La Roche Ltd and Pfizer Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Skin and skin structure infections are among the most common bacterial infection of skin-related tissues. The increased antimicrobial resistance among both gram-positive and gram-negative bacteria is a rapidly growing reason for hospitalization in complicated skin structural infections. Skin structural infections are usually considered complicated in case of needed surgery combined with antimicrobial therapy. The complicated skin structural infections generally include burns, ulcers, and major underlying diseases that complicate antibiotic treatment. The major symptoms of skin and skin structure infections include pus, blisters, skin sloughing, breakdown, and skin being discolored and painful.
This report aims to provide a comprehensive presentation of the global market for Complicated Skin and Skin Structure Infections Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complicated Skin and Skin Structure Infections Drugs. This report contains market size and forecasts of Complicated Skin and Skin Structure Infections Drugs in global, including the following market information:
Global Complicated Skin and Skin Structure Infections Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Complicated Skin and Skin Structure Infections Drugs Market Sales, 2019-2024, 2025-2030, (Tons)
Global top five Complicated Skin and Skin Structure Infections Drugs companies in 2023 (%)
We surveyed the Complicated Skin and Skin Structure Infections Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Complicated Skin and Skin Structure Infections Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Complicated Skin and Skin Structure Infections Drugs Market Segment Percentages, by Type, 2023 (%)
Tedizolid
Vancomycin
Ceftaroline
Linezolid
Darbavansing
Olivanstar
Tedizolid
Global Complicated Skin and Skin Structure Infections Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Complicated Skin and Skin Structure Infections Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Specialist Clinic
Home Care
Other
Global Complicated Skin and Skin Structure Infections Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Complicated Skin and Skin Structure Infections Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Complicated Skin and Skin Structure Infections Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Complicated Skin and Skin Structure Infections Drugs revenues share in global market, 2023 (%)
Key companies Complicated Skin and Skin Structure Infections Drugs sales in global market, 2019-2024 (Estimated), (Tons)
Key companies Complicated Skin and Skin Structure Infections Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Endo International Inc
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Inc
Dr Reddy's Laboratories Ltd
Abbott
F. Hoffmann-La Roche Ltd
Pfizer Inc
Zydus Group
Lupin
Melinta Therapeutics, Inc
MerLion Pharmaceuticals GmbH
Paratek Pharmaceuticals, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Complicated Skin and Skin Structure Infections Drugs, market overview.
Chapter 2: Global Complicated Skin and Skin Structure Infections Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Complicated Skin and Skin Structure Infections Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Complicated Skin and Skin Structure Infections Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Complicated Skin and Skin Structure Infections Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
